Brain Tumors Suppliers In Europe

Mevion Medical Systems exists to deliver on the promise of proton therapy for cancer centers, clinicians and patients worldwide. We invented compact proton therapy and are continuing to transform the industry and patient care with the MEVION S250 ...

ALBEGA Medical is a newly established pharmaceutical company developing novel radiopharmaceuticals in oncology. Our lead compound is Tetrofosmin (TTF) that we are developing in 3 indications: GLIOTECT - a novel diagnostic for brain tumors, GLIOTHER ...

Cercare Medical is based on +25 years of research in perfusion imaging and artificial intelligence. Our novel biomarkers provide unparalleled patient insights. We are bridging the gap between science and clinical practice. With our amazing ...

Therawis Pharma GmbH is a privately held, profitable oncology-specialized company with offices located in Munich, Germany, and was founded in April 2014. We provide european-wide support in medical & clinical trial development for therapeutics and ...

We are a pioneering medical device company focused on transforming the lives of patients with difficult to treat cancers by applying our discoveries in bioelectromagnetics to targeted treatment of cancer. Our patient-based research using low and ...

Founded in 2005, by Alexandre TOKAY, CEO, and Dr. Michel KHRESTCHATISKY, Scientific Advisor, VECT-HORUS is a spin-off of the NICN UMR7259 (CNRS and Aix-Marseille University) now Institute for NeuroPhysiopathology (INP) directed by Dr. Michel ...

The Asbestos Testing and Consultancy Association (ATaC) is the leading trade association in the UK for the asbestos testing and consulting services sector. ATaC has represented the interests of asbestos testing and consultancy specialists for over ...

We’re proud of what Medstone has achieved so far. We’ve built a platform for pharmacists, we offer artificial intelligence solutions for scientific analyses, and we have our own pharmaceutical wholesale. We do all these things because we have one ...

Stilla Technologies is the multiplex digital PCR company transforming complex genomic data into actionable insights across a wide range of research and clinical applications including cancer and liquid biopsy studies, cell and gene therapies, ...

Nexstim was established in 2000 to commercialise the opportunity of adding navigation to an existing transcranial magnetic stimulation (TMS) technology. The founders believed that navigation and making the TMS visible with the help of navigation is ...